The work published by Hunsperger et al. (2014) evaluated commercial diagnostic kits, resulting in anti-dengue IgM in ELISA with specificity of 78–91% and sensitivity 96–98%, including proving that anti-dengue IgM tests are less sensitive in secondary infections. This evidence concerns the gene CD40LG and infection.